• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-10b-5p 通过靶向 SLC38A2 调节肝癌细胞代谢促进肿瘤生长。

miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2.

机构信息

Breast Surgery Department I, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P.R. China.

Liver and gallbladder surgery Department I, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P.R. China.

出版信息

Cancer Biol Ther. 2024 Dec 31;25(1):2315651. doi: 10.1080/15384047.2024.2315651. Epub 2024 Feb 23.

DOI:10.1080/15384047.2024.2315651
PMID:38390840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10896153/
Abstract

Metabolic reprogramming plays a critical role in hepatocarcinogenesis. However, the mechanisms regulating metabolic reprogramming in primary liver cancer (PLC) are unknown. Differentially expressed miRNAs between PLC and normal tissues were identified using bioinformatic analysis. RT-qPCR was used to determine miR-10b-5p and SCL38A2 expression levels. IHC, WB, and TUNEL assays were used to assess the proliferation and apoptosis of the tissues. The proliferation, migration, invasion, and apoptosis of PLC cells were determined using the CCK-8 assay, Transwell assay, and flow cytometry. The interaction between miR-10b-5p and SLC38A2 was determined using dual-luciferase reporter assay. A PLC xenograft model in BALB/c nude mice was established, and tumorigenicity and SLC38A2 expression were estimated. Finally, liquid chromatography - mass spectrometry (LC-MS) untargeted metabolomics was used to analyze the metabolic profiles of xenograft PLC tissues in nude mice. miR-10b-5p was a key molecule in the regulation of PLC. Compared with para-carcinoma tissues, miR-10b-5p expression was increased in tumor tissues. miR-10b-5p facilitated proliferation, migration, and invasion of PLC cells. Mechanistically, miR-10b-5p targeted SLC38A2 to promote PLC tumor growth. Additionally, miR-10b-5p altered the metabolic features of PLC . Overexpression of miR-10b-5p resulted in remarkably higher amounts of lumichrome, folic acid, octanoylcarnitine, and Beta-Nicotinamide adenine dinucleotide, but lower levels of 2-methylpropanal, glycyl-leucine, and 2-hydroxycaproic acid. miR-10b-5p facilitates the metabolic reprogramming of PLC by targeting SLC38A2, which ultimately boosts the proliferation, migration, and invasion of PLC cells. Therefore, miR-10b-5p and SLC38A2 are potential targets for PLC diagnosis and treatment.

摘要

代谢重编程在肝癌发生中起着关键作用。然而,调控原发性肝癌(PLC)代谢重编程的机制尚不清楚。通过生物信息学分析鉴定 PLC 与正常组织之间差异表达的 miRNAs。使用 RT-qPCR 测定 miR-10b-5p 和 SCL38A2 的表达水平。使用免疫组化、WB 和 TUNEL 检测评估组织的增殖和凋亡。使用 CCK-8 测定、Transwell 测定和流式细胞术测定 PLC 细胞的增殖、迁移、侵袭和凋亡。使用双荧光素酶报告基因测定确定 miR-10b-5p 和 SLC38A2 之间的相互作用。在 BALB/c 裸鼠中建立 PLC 异种移植模型,并评估致瘤性和 SLC38A2 表达。最后,使用液相色谱-质谱(LC-MS)非靶向代谢组学分析裸鼠异种移植 PLC 组织的代谢谱。miR-10b-5p 是调控 PLC 的关键分子。与癌旁组织相比,肿瘤组织中 miR-10b-5p 的表达增加。miR-10b-5p 促进 PLC 细胞的增殖、迁移和侵袭。在机制上,miR-10b-5p 靶向 SLC38A2 以促进 PLC 肿瘤生长。此外,miR-10b-5p 改变了 PLC 的代谢特征。miR-10b-5p 的过表达导致亮氨酸、叶酸、辛酰肉碱和 Beta-Nicotinamide adenine dinucleotide 的含量显著增加,而 2-甲基丙醛、甘氨酰-亮氨酸和 2-羟基己酸的含量降低。miR-10b-5p 通过靶向 SLC38A2 促进 PLC 的代谢重编程,从而最终增强 PLC 细胞的增殖、迁移和侵袭。因此,miR-10b-5p 和 SLC38A2 是 PLC 诊断和治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/4be04776b3ff/KCBT_A_2315651_F0006b_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/922f09c23414/KCBT_A_2315651_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/b3aecfc4cd32/KCBT_A_2315651_F0002a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/01f0edc0645d/KCBT_A_2315651_F0002b_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/62eb952f35ee/KCBT_A_2315651_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/19813eb37929/KCBT_A_2315651_F0004a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/1bddeb75287d/KCBT_A_2315651_F0004b_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/0cb74ea891f1/KCBT_A_2315651_F0005a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/fbdad4afe772/KCBT_A_2315651_F0005b_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/4b2a06399668/KCBT_A_2315651_F0006a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/4be04776b3ff/KCBT_A_2315651_F0006b_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/922f09c23414/KCBT_A_2315651_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/b3aecfc4cd32/KCBT_A_2315651_F0002a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/01f0edc0645d/KCBT_A_2315651_F0002b_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/62eb952f35ee/KCBT_A_2315651_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/19813eb37929/KCBT_A_2315651_F0004a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/1bddeb75287d/KCBT_A_2315651_F0004b_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/0cb74ea891f1/KCBT_A_2315651_F0005a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/fbdad4afe772/KCBT_A_2315651_F0005b_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/4b2a06399668/KCBT_A_2315651_F0006a_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/208b/10896153/4be04776b3ff/KCBT_A_2315651_F0006b_OC.jpg

相似文献

1
miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2.miR-10b-5p 通过靶向 SLC38A2 调节肝癌细胞代谢促进肿瘤生长。
Cancer Biol Ther. 2024 Dec 31;25(1):2315651. doi: 10.1080/15384047.2024.2315651. Epub 2024 Feb 23.
2
Hsa_circRNA_001859 regulates pancreatic cancer progression and epithelial-mesenchymal transition through the miR-21-5p/SLC38A2 pathway.Hsa_circRNA_001859 通过 miR-21-5p/SLC38A2 通路调控胰腺癌进展和上皮间质转化。
Cancer Biomark. 2023;37(1):39-52. doi: 10.3233/CBM-220229.
3
MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.微小 RNA-98-5p 通过靶向核因子-κB 诱导激酶抑制乙型肝炎病毒相关肝细胞癌的发生。
Yonsei Med J. 2020 Jun;61(6):460-470. doi: 10.3349/ymj.2020.61.6.460.
4
Matrine Inhibits Proliferation, Invasion, and Migration and Induces Apoptosis of Colorectal Cancer Cells Via miR-10b/PTEN Pathway.苦参碱通过 miR-10b/PTEN 通路抑制结直肠癌细胞的增殖、侵袭和迁移并诱导其凋亡。
Cancer Biother Radiopharm. 2022 Dec;37(10):871-881. doi: 10.1089/cbr.2020.3800. Epub 2020 Sep 9.
5
MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.microRNA-493-5p 通过靶向 VAMP2 促进肝癌细胞凋亡,抑制增殖和侵袭。
Int J Mol Med. 2018 Mar;41(3):1740-1748. doi: 10.3892/ijmm.2018.3358. Epub 2018 Jan 2.
6
CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.环状 RNA MTO1 通过调控 Wnt/β-catenin 信号通路和上皮间质转化抑制 miR-541-5p/ZIC1 轴抑制肝癌进展。
Cell Death Dis. 2021 Dec 20;13(1):12. doi: 10.1038/s41419-021-04464-3.
7
Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.miR-10b-3p 的上调通过靶向 CMTM5 促进肝癌细胞的进展。
J Cell Mol Med. 2018 Jul;22(7):3434-3441. doi: 10.1111/jcmm.13620. Epub 2018 Apr 24.
8
LINC00491 promotes cell growth and metastasis through miR-324-5p/ROCK1 in liver cancer.LINC00491通过miR-324-5p/ROCK1促进肝癌细胞的生长和转移。
J Transl Med. 2021 Dec 7;19(1):504. doi: 10.1186/s12967-021-03139-z.
9
MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.microRNA-183-5p 通过靶向 PDCD4 促进人肝癌的恶性进展。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20201761.
10
MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.miR-106b-5p 通过与 HPGD 结合调节食管鳞状细胞癌的进展。
BMC Cancer. 2022 Mar 22;22(1):308. doi: 10.1186/s12885-022-09404-8.

引用本文的文献

1
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
2
Exploring the potential function of high expression of in regulating ubiquitination in hepatocellular carcinoma.探索[具体物质]高表达在调节肝细胞癌泛素化中的潜在功能。 (注:原文中“in regulating ubiquitination”前缺少具体物质,这里假设用[具体物质]替代)
World J Gastrointest Oncol. 2025 May 15;17(5):103594. doi: 10.4251/wjgo.v17.i5.103594.
3
MiR-122-5p inhibits the epithelial mesenchymal transition of liver cancer cells by inducing hiPSCs to differentiate into hepatocyte-like cells.

本文引用的文献

1
AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.AGA 临床实践指南:肝细胞癌的系统治疗。
Gastroenterology. 2022 Mar;162(3):920-934. doi: 10.1053/j.gastro.2021.12.276.
2
The hallmarks of cancer metabolism: Still emerging.癌症代谢的特征:仍在不断涌现。
Cell Metab. 2022 Mar 1;34(3):355-377. doi: 10.1016/j.cmet.2022.01.007. Epub 2022 Feb 4.
3
Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.上调 microRNA-373-3p 促进肝癌细胞凋亡并抑制其转移。
微小RNA-122-5p通过诱导人诱导多能干细胞分化为肝细胞样细胞来抑制肝癌细胞的上皮-间质转化。
Eur J Histochem. 2025 Apr 7;69(2). doi: 10.4081/ejh.2025.4190. Epub 2025 May 6.
4
Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade.miR-10b-5p通过调节PKP3/RIPK3/MLKL级联反应诱导肺腺癌发生坏死性凋亡。
Oncol Rep. 2025 May;53(5). doi: 10.3892/or.2025.8889. Epub 2025 Mar 21.
5
Long noncoding RNA SNHG4 promotes glioma progression via regulating miR-367-3p/MYO1B axis in zebrafish xenografts.长链非编码RNA SNHG4通过调控斑马鱼异种移植瘤中的miR-367-3p/MYO1B轴促进胶质瘤进展。
Hum Cell. 2025 Feb 14;38(2):53. doi: 10.1007/s13577-025-01183-1.
6
miRNAs in HCC, pathogenesis, and targets.肝癌中的微小RNA、发病机制及靶点。
Hepatology. 2024 Nov 29. doi: 10.1097/HEP.0000000000001177.
7
MiR-10b-5p attenuates spinal cord injury and alleviates LPS-induced PC12 cells injury by inhibiting TGF-β1 decay and activating TGF-β1/Smad3 pathway through PTBP1.miR-10b-5p 通过抑制 TGF-β1 衰减并激活 TGF-β1/Smad3 通路来减轻脊髓损伤并缓解 LPS 诱导的 PC12 细胞损伤,其作用机制与 PTBP1 有关。
Eur J Med Res. 2024 Nov 19;29(1):554. doi: 10.1186/s40001-024-02133-7.
8
Role and clinical value of serum hsa_tsr011468 in lung adenocarcinoma.血清 hsa_tsr011468 在肺腺癌中的作用和临床价值。
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13350. Epub 2024 Oct 4.
9
The downregulation of SASH1 expression promotes breast cancer occurrence and invasion accompanied by the activation of PI3K-Akt-mTOR signaling pathway.SASH1 表达下调促进乳腺癌的发生和浸润,并伴有 PI3K-Akt-mTOR 信号通路的激活。
Sci Rep. 2024 Sep 19;14(1):21914. doi: 10.1038/s41598-024-72562-1.
Bioengineered. 2022 Jan;13(1):1304-1319. doi: 10.1080/21655979.2021.2014616.
4
Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer.肝癌中的缺氧、代谢重编程与耐药性
Cells. 2021 Jul 6;10(7):1715. doi: 10.3390/cells10071715.
5
SNAT2/SLC38A2 Confers the Stemness of Gastric Cancer Cells via Regulating Glutamine Level.SLC38A2 通过调节谷氨酰胺水平赋予胃癌细胞干性。
Dig Dis Sci. 2022 Jul;67(7):2948-2956. doi: 10.1007/s10620-021-07110-2. Epub 2021 Jun 25.
6
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1.致癌性 KRAS 突变通过 hippo 信号通路效应蛋白 YAP1 增强结直肠癌细胞对氨基酸的摄取。
Mol Oncol. 2021 Oct;15(10):2782-2800. doi: 10.1002/1878-0261.12999. Epub 2021 Jun 18.
7
Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation.外泌体miR-10b-5p介导胃癌细胞与成纤维细胞的细胞通讯并促进细胞增殖。
J Cancer. 2021 Feb 21;12(7):2140-2150. doi: 10.7150/jca.47817. eCollection 2021.
8
Cellular heterogeneity and plasticity in liver cancer.肝癌中的细胞异质性和可塑性。
Semin Cancer Biol. 2022 Jul;82:134-149. doi: 10.1016/j.semcancer.2021.02.015. Epub 2021 Feb 26.
9
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.从肝硬化到癌症:MicroRNAs 在肝癌发生中的作用。
Int J Mol Sci. 2021 Feb 2;22(3):1492. doi: 10.3390/ijms22031492.
10
LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p.长链非编码RNA PDCD4-AS1通过miR-10b-5p增加IQGAP2的表达来减轻三阴性乳腺癌。
Transl Oncol. 2021 Jan;14(1):100958. doi: 10.1016/j.tranon.2020.100958. Epub 2020 Nov 25.